Revenue Estimates Analysis of Proofpoint, Inc.(NASDAQ:PFPT): Tonix Pharmaceuticals Holding Corp.(NASDAQ:TNXP)

0
6

Proofpoint, Inc. (PFPT) will report its next earnings on Apr 25 AMC. The company reported the earnings of $0.51/Share in the last quarter where the estimated EPS by analysts was $0.35/share. The difference between the expected and actual EPS was $0.16/share, which represents an Earnings surprise of 45.7%.

Many analysts are providing their Estimated Earnings analysis for Proofpoint, Inc. and for the current quarter 27 analysts have projected that the stock could give an Average Earnings estimate of $0.33/share. These analysts have also projected a Low Estimate of $0.31/share and a High Estimate of $0.38/share.

In case of Revenue Estimates, 24 analysts have provided their consensus Average Revenue Estimates for Proofpoint, Inc. as 199.28 Million. According to these analysts, the Low Revenue Estimate for Proofpoint, Inc. is 198.21 Million and the High Revenue Estimate is 201.1 Million. The company had Year Ago Sales of 162.46 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for PFPT to be 13.3%. They are projecting Next Quarter growth of 42.31%. For the next 5 years, Proofpoint, Inc. is expecting Growth of 32.62% per annum, whereas in the past 5 years the growth was 12.93% per annum.

Some buy side analysts are also providing their Analysis on Proofpoint, Inc., where 3 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Proofpoint, Inc. might touch $160 high while the Average Price Target and Low price Target is $127 and $95 respectively.

Proofpoint, Inc. closed its last trading session at $119.94 with the gain of 2.18%. The Market Capitalization of the company stands at 6.69 Billion. The Company has 52-week high of $130.27 and 52-week low of $75.92. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.08% where SMA50 and SMA200 are 3.22% and 14.54% respectively. The Company Touched its 52-Week High on 05/10/18 and 52-Week Low on 10/26/18.

The Relative Volume of the company is 0.83 and Average Volume (3 months) is 611.39 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 54.49.

The company shows its Return on Assets (ROA) value of -9.2%. The Return on Equity (ROE) value stands at -25.7%. While it’s Return on Investment (ROI) value is -17.3%.

While looking at the Stock’s Performance, Proofpoint, Inc. currently shows a Weekly Performance of 2.87%, where Monthly Performance is 0.44%, Quarterly performance is 33.74%, 6 Months performance is 29.92% and yearly performance percentage is -0.32%. Year to Date performance value (YTD perf) value is 46.22%. The Stock currently has a Weekly Volatility of 1.76% and Monthly Volatility of 2.42%.

Tonix Pharmaceuticals Holding Corp. (TNXP) will report its next earnings on Mar 18. The company reported the earnings of $-6.1/Share in the last quarter where the estimated EPS by analysts was $-3.66/share. The difference between the expected and actual EPS was $-2.44/share, which represents an Earnings surprise of -66.7%.

Many analysts are providing their Estimated Earnings analysis for Tonix Pharmaceuticals Holding Corp. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.96/share. These analysts have also projected a Low Estimate of $-0.96/share and a High Estimate of $-0.96/share.

Some buy side analysts are also providing their Analysis on Tonix Pharmaceuticals Holding Corp., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Tonix Pharmaceuticals Holding Corp. might touch $4.5 high while the Average Price Target and Low price Target is $4.5 and $4.5 respectively.

Tonix Pharmaceuticals Holding Corp. closed its last trading session at $2.6 with the loss of -3.46%. The Market Capitalization of the company stands at 15.84 Million. The Company has 52-week high of $51.10 and 52-week low of $1.70. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.82% where SMA50 and SMA200 are 9.69% and -72.39% respectively. The Company Touched its 52-Week High on 06/07/18 and 52-Week Low on 01/31/19.

The Relative Volume of the company is 0.14 and Average Volume (3 months) is 1.57 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -143.7%. The Return on Equity (ROE) value stands at -163.5%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Tonix Pharmaceuticals Holding Corp. currently shows a Weekly Performance of -7.38%, where Monthly Performance is -20.82%, Quarterly performance is 17.84%, 6 Months performance is -56.72% and yearly performance percentage is -91.77%. Year to Date performance value (YTD perf) value is 14.09%. The Stock currently has a Weekly Volatility of 5.44% and Monthly Volatility of 8.19%.

SHARE